European Companies Search Engine
Registration · Managing Director: Frank Graichen · Authorized signatory (ppa): Sigrid Uhlemann · Capital: €250,000 · Shareholder agreement · Proxy policy · Corporate Purpose Hrb30 Jun 2008 German Trade Register Announcements, Germany (27/06/2008)
Overview
Text
DQS Medizinprodukte GmbH, Frankfurt am Main (
August-Schanz-Straße 21, 60433 Frankfurt am Main
). GmbH. Social Contract of May 5, 2008. The ame is: (a) the promotion of the economy. For this purpose, the company shall, upon request, check whether management systems, declarations by companies, etc. comply with recognised rules of technology (in particular DIN standards, European standards and international standards) or other rules agreed by the company with the client. The company focuses on medical devices and related industries. (b) Reports shall be drawn up on the outcome of the evaluations. The finding that the management system under investigation, the declarations of companies, etc. comply with the agreed rules is confirmed by a certificate upon request. (c) The Company shall ensure its objectivity, neutrality and independence in all assessments and certifications; accreditation rules are observed in particular. d) Society sees itself as a service partner for the economy. It directs its activities towards the added value through effective management systems of its clients. Share capital: EUR 250,000.00. General representation scheme: If only one managing director is appointed, he shall represent the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. Managing Director: Graichen, Frank, Frankfurt am Main, *??.??.????, authorized to represent one another; with the power to enter into legal transactions on behalf of the company in its own name or as a representative of a third party. Single procurator: Uhlemann, Sigrid, Bad Vilbel, *??.??.????. Created by spin-off of assets of DQS GmbH Deutsche Gesellschaft for the certification of management systems based in Frankfurt am Main (Amtsgericht Frankfurt am Main HRB 54018) in accordance with the spin-off plan of May 5, 2008 and the approval decisions of the participating legal entities of the same day. Date of registration of the spin-off in the commercial register of the transferring entity: June 27, 2008 It is disclosed a.s. not registered: if the creditors of the entities participating in the spin-off have been notified in writing of their claim on grounds within six months of the date on which the registration of the spin-off in the register of the registered office of the entity of which they are creditors, in accordance with Paragraphs 125, 19 (3) of the UmwG, they must be made aware of their claim in writing, provided that they cannot demand satisfaction. However, creditors are only entitled to this right if they demonstrate that the spin-off jeopardises the fulfilment of their claim.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: DQS Medizinprodukte GmbH, Frankfurt a. Main, Germany.